In HPV+ HNSCC, TGFB1 is expressed higher in HPV 33+ compared with HPV16+ patients with less CD8+ T cell infiltration and worse prognosis (22). This evidence concerns the gene TGFB1 and head and neck squamous cell carcinoma.